Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg

Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg

Background. We compared the prevalence of SARS-CoV-2 IgG/IgM in multiple sclerosis (MS), low-risk, and high-risk populations and explored possible clinical correlates. Methods. In this cross-sectional study, we recruited MS patients, low-risk (university staff from non-clinical departments), and hig...

Full description

Bibliographic Details
Main Authors: Nicola Capasso, Raffaele Palladino, Emma Montella, Francesca Pennino, Roberta Lanzillo, Antonio Carotenuto, Maria Petracca, Rosa Iodice, Aniello Iovino, Francesco Aruta, Viviana Pastore, Antonio Riccardo Buonomo, Emanuela Zappulo, Ivan Gentile, Maria Triassi, Vincenzo Brescia Morra, Marcello Moccia
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Journal of Clinical Medicine
Subjects:
multiple sclerosis
COVID-19
infection
antibody
seroprevalence
Online Access:https://www.mdpi.com/2077-0383/9/12/4066

Internet

https://www.mdpi.com/2077-0383/9/12/4066

Similar Items